{"id":1004099,"date":"2026-09-17T03:04:11","date_gmt":"2026-09-17T07:04:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/"},"modified":"2026-09-17T03:04:11","modified_gmt":"2026-09-17T07:04:11","slug":"idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/","title":{"rendered":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdecimal { list-style-type: decimal }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection<\/b><\/p>\n<p class=\"bwalignc\"><i>Expanded testing menu now detects more intestinal parasites during routine visits<\/i><\/p>\n<p>WESTBROOK, Maine&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nIDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx\u2122<sup \/>antigen testing platform in the United Kingdom with taeniid tapeworm, including <i>Taenia<\/i> and <i>Echinococcus <\/i>species. Proven to detect up to twice as many intestinal parasite infections earlier than faecal flotation alone,<sup>1<\/sup> Faecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg\" alt=\"IDEXX Faecal Dx\u2122 antigen testing platform menu\" \/><\/p>\n<p style=\"font-size:85%\">IDEXX Faecal Dx\u2122 antigen testing platform menu<\/p>\n<\/div>\n<p>\nSince launching in 2012, more than 50 million Faecal Dx antigen tests have been run worldwide,<sup>2 <\/sup>reflecting consistent use in practice over time. With each menu expansion, Faecal Dx has grown into a diagnostic platform with increasing clinical scope.<\/p>\n<p>\n\u201cThis advancement reflects how we innovate at IDEXX, developing platforms that grow with our customers as care evolves,\u201d said Mike Erickson, President and CEO of IDEXX. \u201cBy broadening the insight available through Faecal Dx, we\u2019re making faecal testing easier to incorporate into everyday decision-making, helping veterinary teams reach more pets with greater confidence.\u201d<\/p>\n<p><i>Taenia<\/i> and <i>Echinococcus<\/i> species are recognized by the European Scientific Counsel Companion Animal Parasites (ESCCAP) as clinically important parasites.<sup>3,4<\/sup> Due to its zoonotic risk, ESCCAP identifies <i>Echinococcus<\/i> species as one of the three key parasite groups requiring preventive control in dogs and cats.<sup>3<\/sup> With this addition, Faecal Dx antigen testing now detects seven of the most clinically relevant intestinal parasite groups, including hookworm, roundworm, whipworm, flea tapeworm, taeniid tapeworms, <i>Cystoisospora<\/i> and <i>Giardia<\/i> (in select panels).<\/p>\n<p>\nCurrent Faecal Dx antigen testing panels and profiles for IDEXX Reference Laboratories customers in the United Kingdom now include taeniid tapeworm detection at no additional cost.* Faecal Dx test results returning positive for taeniid tapeworms will automatically initiate a complimentary follow-up <i>Echinococcus <\/i>RealPCR test.*<\/p>\n<p>\nFor more information, please visit the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.idexx.co.uk%2Fen-gb%2Fveterinary%2Freference-laboratories%2Ffecal-testing%2Ffecal-dx-antigen-test%2F&amp;esheet=54605448&amp;newsitemid=20260917879004&amp;lan=en-US&amp;anchor=Faecal+Dx+antigen+testing&amp;index=1&amp;md5=875015c3354ee4cf5534f16535672acf\">Faecal Dx antigen testing<\/a> web page.<\/p>\n<p>\n*IDEXX reserves the right to modify, suspend, or discontinue the offering at its sole discretion.<\/p>\n<p><b>References<\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nBurton KW, Michael H, Drake C. The utility of coproantigen testing in screening populations. <i>Vet Parasitol<\/i>. 2025;336:110459. doi:10.1016\/j.vetpar.2025.110459<\/p>\n<\/li>\n<li>\nData on file at IDEXX Laboratories, Inc. Westbrook, Maine USA: IDEXX Faecal Dx antigen test results collected January 2012\u2013April 2026.<\/p>\n<\/li>\n<li>\nEuropean Scientific Counsel Companion Animal Parasites. ESCCAP guidelines: <i>Taenia<\/i> spp. June 2025. Accessed September 1, 2026. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.esccap.org%2Fguidelines%2Fgl1%2F&amp;esheet=54605448&amp;newsitemid=20260917879004&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.esccap.org%2Fguidelines%2Fgl1%2F&amp;index=2&amp;md5=11f265cec40c79df423aac39863cbbc0\">https:\/\/www.esccap.org\/guidelines\/gl1\/<\/a><\/li>\n<li>\nEuropean Scientific Counsel Companion Animal Parasites. ESCCAP guidelines: <i>Echinococcus<\/i> spp. June 2025. Accessed September 1, 2026. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.esccap.org%2Fmodular-guidelines%2Fmg1%2F&amp;esheet=54605448&amp;newsitemid=20260917879004&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.esccap.org%2Fmodular-guidelines%2Fmg1%2F&amp;index=3&amp;md5=b0b77ddd035e3b19560d2a150363d158\">https:\/\/www.esccap.org\/modular-guidelines\/mg1\/<\/a><\/li>\n<\/ol>\n<p><strong>About IDEXX<\/strong><\/p>\n<p>\nIDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions\u2014to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&amp;P 500\u2122 Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.idexx.co.uk%2Fen-gb%2F&amp;esheet=54605448&amp;newsitemid=20260917879004&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.idexx.co.uk%2Fen-gb%2F&amp;index=4&amp;md5=618512971f187469ee3b41b4b9bc1cb1\">https:\/\/www.idexx.co.uk\/en-gb\/<\/a>.<\/p>\n<p><b>Forward-Looking Statement<\/b><\/p>\n<p>\nCertain statements made in the materials on IDEXX\u2019s website, in social media posts, or via other media or channels may constitute forward-looking statements. Forward-looking statements are not statements of historical fact and can be identified by the use of words such as \u201cexpects\u201d, \u201cmay\u201d, \u201canticipates\u201d, \u201cintends\u201d, \u201cwill\u201d, \u201cplans\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, and similar expressions. These forward-looking statements reflect our current expectations as of the date they are made. They are provided for informational purposes only and do not constitute representations, warranties, or commitments of any kind. No guarantee is given that any anticipated outcome, product, feature, or timeline will be achieved or delivered. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied, including but not limited to changes in regulatory requirements, market conditions, technology developments, and the availability of components and raw materials. IDEXX accepts no responsibility or liability for any decision made in reliance on a forward-looking statement. Any binding commitments between IDEXX and a business partner are limited exclusively to the terms set out in the applicable written agreement between the parties. These forward-looking statements speak only as of the date made. IDEXX undertakes no obligation to publicly update or revise any forward-looking statement, except as required by applicable law. The timing of release, delivery, or availability of any product, service, feature, functionality, enhancement, or expansion referenced in any IDEXX material is subject to change at IDEXX\u2019s discretion and may not occur as planned or at all. Purchasing decisions should be based on products, services, features, and functionalities that are currently available. No statement in this material constitutes a binding commitment to deliver any particular product, feature, or functionality.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260917879004r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/<\/a><\/span><\/p>\n<p><b>Media Relations<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:media@idexx.com\">media@idexx.com<\/a><\/p>\n<p><b>Investor Relations<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:investorrelations@idexx.com\">investorrelations@idexx.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Maine Europe United States United Kingdom North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Veterinary Technology Pets Health Technology Software Practice Management Health Consumer Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/3\/Fecal_Dx_Press_Release_Image_UK.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">IDEXX Faecal Dx\u2122 antigen testing platform menu<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/1763442\/3\/1-IDEXX_Black.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine&#8211;(BUSINESS WIRE)&#8211; IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx\u2122antigen testing platform in the United Kingdom with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than faecal flotation alone,1 Faecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/ IDEXX Faecal Dx\u2122 antigen testing platform menu Since launching in 2012, more &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1004099","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine&#8211;(BUSINESS WIRE)&#8211; IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx\u2122antigen testing platform in the United Kingdom with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than faecal flotation alone,1 Faecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/ IDEXX Faecal Dx\u2122 antigen testing platform menu Since launching in 2012, more &hellip; Continue reading &quot;IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-17T07:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection\",\"datePublished\":\"2026-09-17T07:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/\"},\"wordCount\":926,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260917879004\\\/en\\\/2902673\\\/4\\\/Fecal_Dx_Press_Release_Image_UK.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/\",\"name\":\"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260917879004\\\/en\\\/2902673\\\/4\\\/Fecal_Dx_Press_Release_Image_UK.jpg\",\"datePublished\":\"2026-09-17T07:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260917879004\\\/en\\\/2902673\\\/4\\\/Fecal_Dx_Press_Release_Image_UK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260917879004\\\/en\\\/2902673\\\/4\\\/Fecal_Dx_Press_Release_Image_UK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/","og_locale":"en_US","og_type":"article","og_title":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk","og_description":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine&#8211;(BUSINESS WIRE)&#8211; IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx\u2122antigen testing platform in the United Kingdom with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than faecal flotation alone,1 Faecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260917879004\/en\/ IDEXX Faecal Dx\u2122 antigen testing platform menu Since launching in 2012, more &hellip; Continue reading \"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-17T07:04:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection","datePublished":"2026-09-17T07:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/"},"wordCount":926,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/","name":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg","datePublished":"2026-09-17T07:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260917879004\/en\/2902673\/4\/Fecal_Dx_Press_Release_Image_UK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taeniid-tapeworm-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1004099"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004099\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1004099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1004099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1004099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}